CHARLES WU

Track

Insider profile

CHARLES WU's trades of Gyre Therapeutics, Inc.'s stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Proposed sale
Price
269.63
Quantity 56,109
Value US$3,048,789
Transaction date
Proposed sale
Price
35.04
Quantity 35,083
Value US$4,929,087
Transaction date
Proposed sale
Price
339.78
Quantity 74,153
Value US$2,410,171
Transaction date
Proposed sale
Price
17.29
Quantity 777
Value US$13,433
Transaction date
Proposed sale
Price
17.00
Quantity 729
Value US$12,393
Transaction date
Proposed sale
Price
16.69
Quantity 3,271
Value US$54,607
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2024-04-09 2024-04-09
PrS Proposed sale
56,109
269.63
US$3,048,789 		56,109 269.63 US$3,048,789
2024-04-08 2024-04-08
PrS Proposed sale
35,083
35.04
US$4,929,087 		35,083 35.04 US$4,929,087
2024-04-05 2024-04-05
PrS Proposed sale
74,153
339.78
US$2,410,171 		74,153 339.78 US$2,410,171
2024-04-04 2024-04-04
PrS Proposed sale
777
17.29
US$13,433 		777 17.29 US$13,433
2024-04-03 2024-04-03
PrS Proposed sale
729
17.00
US$12,393 		729 17.00 US$12,393
2024-04-02 2024-04-02
PrS Proposed sale
3,271
16.69
US$54,607 		3,271 16.69 US$54,607